Bolt Biotherapeutics, Inc.
BOLT
$4.28
$0.081.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.58M | -33.38M | -42.68M | -50.71M | -63.35M |
| Total Depreciation and Amortization | 1.10M | 1.29M | 1.46M | 1.61M | 1.72M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.66M | 4.35M | 5.10M | 5.53M | 7.27M |
| Change in Net Operating Assets | -10.68M | -12.12M | -11.00M | -7.79M | -3.55M |
| Cash from Operations | -34.51M | -39.85M | -47.12M | -51.36M | -57.90M |
| Capital Expenditure | -72.00K | -72.00K | -72.00K | -41.00K | -41.00K |
| Sale of Property, Plant, and Equipment | 31.00K | 963.00K | 963.00K | 1.11M | 1.11M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.72M | 43.41M | 54.57M | 53.64M | 60.85M |
| Cash from Investing | 37.67M | 44.30M | 55.46M | 54.71M | 61.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.00K | 19.00K | 43.00K | 43.00K | 108.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.00K | 19.00K | 43.00K | 43.00K | 108.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.19M | 4.47M | 8.38M | 3.40M | 4.13M |